½ÃÀ庸°í¼­
»óǰÄÚµå
1608185

¼¼°èÀÇ ÇÁ·ÎÅ×ÀÎ ¿£Áö´Ï¾î¸µ¿ë ½ÃÇè±â°ü ÀÚµ¿È­ ½ÃÀå : ÀåÄ¡º°, ¿ëµµº° ¿¹Ãø(2025-2030³â)

Lab Automation in Protein Engineering Market by Equipment (Automated Liquid Handlers, Automated Plate Handlers, Automated Storage), Application (Hospitals & Clinics, Laboratories & Academics) - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 197 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ÇÁ·ÎÅ×ÀÎ ¿£Áö´Ï¾î¸µ¿ë ½ÃÇè±â°ü ÀÚµ¿È­ ½ÃÀåÀº 2023³â¿¡ 20¾ï 1,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 21¾ï 5,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 9.16%·Î ¼ºÀåÇÏ¿©, 2030³â¿¡´Â 37¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÇÁ·ÎÅ×ÀÎ ¿£Áö´Ï¾î¸µ¿ë ½ÃÇè±â°ü ÀÚµ¿È­ÀÇ ¹üÀ§¿Í Á¤ÀÇ¿¡´Â µ¹¿¬º¯ÀÌ À¯¹ß, ´Ü¹éÁú ¹ßÇö, Á¤Á¦, ºÐ¼® µî ´Ù¾çÇÑ ´Ü¹éÁú ¿£Áö´Ï¾î¸µ ÇÁ·Î¼¼½º¸¦ °£¼ÒÈ­ÇÏ´Â °í±Þ ÀÚµ¿È­ ±â¼úÀÇ ÅëÇÕÀÌ Æ÷ÇԵ˴ϴÙ. Á¤È®¼º, ÀçÇö¼ºÀ» ³ôÀÌ´Â µ¿½Ã¿¡ ÀÎÀ§Àû ½Ç¼ö, ¿î¿µ ºñ¿ë, ³ëµ¿ Áý¾àÀûÀÎ ¼öµ¿ ÇÁ·ÎÅäÄÝÀ» ÁÙÀ̱â À§ÇØ ÇÊ¿äÇÕ´Ï´Ù. ÃÖÁ¾ ¿ëµµ´Â ÁַΠâ¾à, ¿¬±¸°³¹ß, ÇÕ¼º »ý¹°ÇÐÀ̸ç, ¿ëµµ´Â Á¦¾à, »ý¸í°øÇп¡¼­ Çмú¿¬±¸, »ê¾÷ºÐ¾ß¿¡ À̸£±â±îÁö ´Ù¾çÇÕ´Ï´Ù. »ý¸í °øÇÐ ¿¬±¸¿¡ ´ëÇÑ ÀÚ±Ý Á¦°ø Áõ°¡, µ¥ÀÌÅÍ ±¸µ¿ ÀλçÀÌÆ®À»À§ÇÑ AI ¹× ¸Ó½Å·¯´×ÀÇ ±Þ¼ÓÇÑ Áøº¸, ¼ÒÇüÈ­ ¹× ³ôÀº 󸮷® ½ºÅ©¸®´×¿¡ ´ëÇÑ µ¿Çâ Áõ°¡ ¶ÇÇÑ ½ÅÈï±¹ ½ÃÀå¿¡¼­ÀÇ ½ÇÇè½Ç ÀÚµ¿È­ ±â¼úÀÇ ÀÌ¿ë È®´ë¿Í Á¾ÇÕÀûÀÎ ¿öÅ©Ç÷ο츦 ½ÇÇöÇÏ´Â ÅëÇÕ ½Ã½ºÅÛÀÇ °³Ã´¿¡µµ »õ·Î¿î ºñÁî´Ï½º ±âȸ°¡ Àáµé°í ÀÖ½À´Ï´Ù. ±âÁ¸ ½Ã½ºÅÛ°úÀÇ ÅëÇÕ º¹À⼺, ÀÚµ¿È­ ±â¼úÀ» °ü¸®ÇÏ´Â ¼÷·ÃÀÚÀÇ Áö¼ÓÀûÀÎ ÇÊ¿ä µîÀÇ °úÁ¦´Â ¿©ÀüÈ÷ ³²¾Æ ÀÖ½À´Ï´Ù. »óÈ£ ¿î¿ë¼º°ú È®À强À» °®Ãá »ç¿ëÀÚ Ä£È­ÀûÀÌ°í ºñ¿ë È¿À²ÀûÀÎ ÀÚµ¿È­ ¼Ö·ç¼ÇÀ» âÃâÇϱâ À§ÇÑ ±â¼ú Çõ½ÅÀ» °è¼ÓÇØ¾ß ÇÕ´Ï´Ù. °³¹ß, º¹ÀâÇÑ ÀÛ¾÷À»À§ÇÑ ·Îº¿ ½Ã½ºÅÛ °­È­,º¸´Ù È¿À²ÀûÀÎ ´Ü¹éÁú ºÐ¼®À»À§ÇÑ ½ÇÇè½Ç Ĩ ±â¼ú ޱ¸ µîÀÌ ÀÖ½À´Ï´Ù.°æÀï·ÂÀ» ³ôÀ̱â À§Çؼ­´Â ±â¾÷Àº ±â¼ú °øµ¿ °³Ã´À» À§ÇÑ ÆÄÆ®³Ê½Ê¿¡ ÅõÀÚÇÏ¿© ¹Ì°³Ã´ Æ´»õ ½ÃÀå¿¡¼­ ÀÀ¿ë ºÐ¾ßÀÇ ´Ù¾çÈ­¸¦ µµ¸ðÇØ¾ß ÇÕ´Ï´Ù. ¾ø´Â ±â¼úÀÇ Áøº¸¿Í ±ÔÁ¦±âÁØÀÇ ÁøÈ­¿¡ ÃßÁøµÇ°í ÀÖ½À´Ï´Ù. Àü·«Àû ÅõÀÚ¸¦ ÅëÇØ ÀÌ·¯ÇÑ º¯È­¿¡ ´ëÀÀÇÏ°í ±â¼ú µ¿ÇâÀ» ¼±Á¡ÇØ ³ª°¡´Â °ÍÀº ÀÌ ºÐ¾ß¿¡¼­ ¸®µåÇÏ´Â °ÍÀ» ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ À־ ¸Å¿ì Áß¿äÇϰí, Áö¼Ó °¡´ÉÇÑ ¼ºÀå°ú ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» È®º¸ÇÏ°Ô µË´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 20¾ï 1,000¸¸ ´Þ·¯
ÃßÁ¤³â(2024) 21¾ï 5,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 37¾ï 2,000¸¸ ´Þ·¯
º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)(%) 9.16%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â ÇÁ·ÎÅ×ÀÎ ¿£Áö´Ï¾î¸µ¿ë ½ÃÇè±â°ü ÀÚµ¿È­ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

´Ü¹éÁú ¿£Áö´Ï¾î¸µÀÇ ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ ÀÛ¿ëÀ¸·Î º¯È­¸¦ °Þ°í ÀÖ½À´Ï´Ù. °áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ ȹµæ ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ À§ÇèÀ» ¿ÏÈ­ÇÒ ¼ö ÀÖÀ¸¸ç, ¼Òºñ ÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ´õ¿í ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ´Ü¹éÁú °øÇÐ ¹× ÀÇ½Ä Çâ»ó ÇÁ·Î±×·¥ Áõ°¡
    • IoT¿¡ ÀÇÇÑ ¿¬±¸¼ÒÀÇ µðÁöÅÐ º¯Çõ µ¿Çâ Áõ°¡
    • »ý¼ºµÇ´Â ¹æ´ëÇÑ µ¥ÀÌÅÍÀÇ È¿À²ÀûÀÎ °ü¸®
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • Ãʱ⠼³Á¤ÀÌ °í°¡
  • ½ÃÀå ±âȸ
    • ÇÁ·ÎÅ×ÀÎ ¿£Áö´Ï¾î¸µ¿ë ½ÃÇè±â°ü ÀÚµ¿È­¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡
    • °Ë»ç °á°úÀÇ Á¤¹Ðµµ¿Í ÀçÇö¼ºÀ» Çâ»ó½Ã۱â À§ÇÑ ¿¬±¸ °³¹ß Ȱµ¿ÀÇ È°¼ºÈ­
  • ½ÃÀåÀÇ °úÁ¦
    • Áß°ß±â¾÷¿¡¼­ÀÇ µµÀÔ·üÀÌ ³·´Ù

Porter's Five Forces : ÇÁ·ÎÅ×ÀÎ ¿£Áö´Ï¾î¸µ¿ë ½ÃÇè±â°ü ÀÚµ¿È­ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces Framework´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces Framework´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®À» ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» Ȱ¿ëÇÏ°í ¾àÁ¡À» ÇØ°áÇϰí ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÔÀ¸·Î½á º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ÇÁ·ÎÅ×ÀÎ ¿£Áö´Ï¾î¸µ¿ë ½ÃÇè±â°ü ÀÚµ¿È­ ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâÀ» ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ÇÁ·ÎÅ×ÀÎ ¿£Áö´Ï¾î¸µ¿ë ½ÃÇè±â°ü ÀÚµ¿È­ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ°¡ °¡´ÉÇÕ´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ÇÁ·ÎÅ×ÀÎ ¿£Áö´Ï¾î¸µ¿ë ½ÃÇè±â°ü ÀÚµ¿È­ ½ÃÀå¿¡¼­ °æÀï ±¸µµ¸¦ ÆÄ¾Ç

´Ü¹éÁú ¿£Áö´Ï¾î¸µÀÇ ½ÇÇè½Ç ÀÚµ¿È­ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù.ÀÇ À§Ä¡ ´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù.ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­ ¹× ÅëÇÕ µ¿ÇâÀ» ¹àÈ÷°í º¥´õ´Â °æÀïÀÌ Ä¡¿­ ÇØÁü¿¡ µû¶ó ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º ÇÁ·ÎÅ×ÀÎ ¿£Áö´Ï¾î¸µ¿ë ½ÃÇè±â°ü ÀÚµ¿È­ ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ÇÁ·ÎÅ×ÀÎ ¿£Áö´Ï¾î¸µ¿ë ½ÃÇè±â°ü ÀÚµ¿È­ ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Á¤º¸¸¦ ±â¹ÝÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ÀÌ Çà·ÄÀ» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× ±ÇÀå ÇÁ·ÎÅ×ÀÎ ¿£Áö´Ï¾î¸µ¿ë ½ÃÇè±â°ü ÀÚµ¿È­ ½ÃÀåÀÇ ¼º°ø¿¡ ´ëÇÑ ±æÀ» ±×¸³´Ï´Ù.

ÇÁ·ÎÅ×ÀÎ ¿£Áö´Ï¾î¸µ¿ë ½ÃÇè±â°ü ÀÚµ¿È­ ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ½ÃÀå¿¡¼­ÀÇ Á¸À縦 °­È­ÇÏ·Á´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÀÌ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» ÀÌ·ç±âÀ§ÇÑ ½Ã½ºÅÛÀ» ±¸Ãà ÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϰí, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° ½ÃÀå, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ, ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ´Ü¹éÁú °øÇÐ ¹× °è¹ß ÇÁ·Î±×·¥ÀÇ È®´ë
      • IoT¿¡ ÀÇÇÑ ¿¬±¸½ÇÀÇ µðÁöÅÐ º¯ÇõÀÇ Æ®·»µå°¡ Áõ°¡
      • »ý¼ºµÇ´Â ¹æ´ëÇÑ ¾çÀÇ µ¥ÀÌÅÍÀÇ È¿°úÀûÀÎ °ü¸®
    • ¾ïÁ¦¿äÀÎ
      • Ãʱ⠼³Á¤¿¡ ºñ¿ëÀÌ µç´Ù
    • ±âȸ
      • ÇÁ·ÎÅ×ÀÎ ¿£Áö´Ï¾î¸µ¿ë ½ÃÇè±â°ü ÀÚµ¿È­¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡
      • °Ë»ç °á°úÀÇ Á¤¹Ðµµ¿Í ÀçÇö¼ºÀ» Çâ»ó½Ã۱â À§ÇÑ ¿¬±¸ °³¹ß Ȱµ¿ Áõ°¡
    • °úÁ¦
      • Áß±Ô¸ð ±â¾÷¿¡¼­ÀÇ Ã¤¿ë·üÀÌ ³·Àº
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå ÇÁ·ÎÅ×ÀÎ ¿£Áö´Ï¾î¸µ¿ë ½ÃÇè±â°ü ÀÚµ¿È­ ½ÃÀå : ±â±âº°

  • ÀÚµ¿ ¾×ü Çڵ鷯
  • ÀÚµ¿ Ç÷¹ÀÌÆ® Çڵ鷯
  • ÀÚµ¿ ½ºÅ丮Áö
  • °Ë»ö ½Ã½ºÅÛ
  • ·Îº¿ ¾Ï

Á¦7Àå ÇÁ·ÎÅ×ÀÎ ¿£Áö´Ï¾î¸µ¿ë ½ÃÇè±â°ü ÀÚµ¿È­ ½ÃÀå : ¿ëµµº°

  • º´¿ø ¹× Ŭ¸®´Ð
  • ¿¬±¸½Ç°ú Çмú±â°ü

Á¦8Àå ¾Æ¸Þ¸®Ä«ÀÇ ÇÁ·ÎÅ×ÀÎ ¿£Áö´Ï¾î¸µ¿ë ½ÃÇè±â°ü ÀÚµ¿È­ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦9Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÇÁ·ÎÅ×ÀÎ ¿£Áö´Ï¾î¸µ¿ë ½ÃÇè±â°ü ÀÚµ¿È­ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦10Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÇÁ·ÎÅ×ÀÎ ¿£Áö´Ï¾î¸µ¿ë ½ÃÇè±â°ü ÀÚµ¿È­ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦11Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Aurora Biomed Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • BMG Labtech GmbH
  • Danaher Corporation
  • Endress Hauser Group Services AG
  • Eppendorf AG
  • F. Hoffmann-La Roche AG
  • General Biologicals Corporation
  • Hamilton Company
  • Hudson Robotics Inc. by Argosy Healthcare Partners
  • Merck KGaA
  • PerkinElmer Inc.
  • QIAGEN GmbH
  • Siemens AG
  • Thermo Fisher Scientific
BJH 24.12.19

The Lab Automation in Protein Engineering Market was valued at USD 2.01 billion in 2023, expected to reach USD 2.15 billion in 2024, and is projected to grow at a CAGR of 9.16%, to USD 3.72 billion by 2030.

The scope and definition of lab automation in protein engineering encompass the integration of advanced automated technologies to streamline various protein engineering processes, such as mutagenesis, protein expression, purification, and analysis. This automation is necessary to enhance throughput, accuracy, and reproducibility while reducing human error, operational costs, and labor-intensive manual protocols. Applications range from pharmaceuticals and biotechnology to academic research and industrial sectors, with end-use primarily focused on drug discovery, development, and synthetic biology. Key growth influencers in this market include rising demand for personalized medicine, increased funding in biotechnology research, rapid advancements in AI and machine learning for data-driven insights, and the growing trend toward miniaturization and high-throughput screening. Moreover, novel opportunities lie in expanding the use of lab automation technology in emerging markets and developing integrated systems for comprehensive workflows. However, challenges persist in terms of high initial capital investments, the complexity of integration with existing systems, and the ongoing need for skilled personnel to manage automated technologies. Addressing these limitations requires continuing innovation in creating user-friendly, cost-effective automation solutions that offer interoperability and scalability. Potential areas of innovation and research include developing next-generation bioinformatics tools, enhancing robotic systems for complex tasks, and exploring lab-on-a-chip technologies for more efficient protein analysis. To gain a competitive edge, companies should invest in partnerships for technology co-development and seek to diversify application areas within untapped niche markets. The nature of the market is highly dynamic and competitively fierce, driven by constant technological advancements and evolving regulatory standards. Adapting to these changes through strategic investments and staying ahead in technology trends will be crucial for businesses aiming to lead in this sector, ensuring sustainable growth and market positioning.

KEY MARKET STATISTICS
Base Year [2023] USD 2.01 billion
Estimated Year [2024] USD 2.15 billion
Forecast Year [2030] USD 3.72 billion
CAGR (%) 9.16%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Lab Automation in Protein Engineering Market

The Lab Automation in Protein Engineering Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing protein engineering and awareness programs
    • Increasing trend of digital transformation for laboratories with IoT
    • Effective management of the huge amount of data generated
  • Market Restraints
    • Expensive Initial Setup
  • Market Opportunities
    • Increase in investments for lab automation in protein engineering
    • Rise in R&D activities for improving accuracy and reproducibility of lab results
  • Market Challenges
    • Low adoption by medium-sized enterprises

Porter's Five Forces: A Strategic Tool for Navigating the Lab Automation in Protein Engineering Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Lab Automation in Protein Engineering Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Lab Automation in Protein Engineering Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Lab Automation in Protein Engineering Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Lab Automation in Protein Engineering Market

A detailed market share analysis in the Lab Automation in Protein Engineering Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Lab Automation in Protein Engineering Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Lab Automation in Protein Engineering Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Lab Automation in Protein Engineering Market

A strategic analysis of the Lab Automation in Protein Engineering Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Lab Automation in Protein Engineering Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Aurora Biomed Inc., Becton, Dickinson and Company, bioMerieux SA, BMG Labtech GmbH, Danaher Corporation, Endress+Hauser Group Services AG, Eppendorf AG, F. Hoffmann-La Roche AG, General Biologicals Corporation, Hamilton Company, Hudson Robotics Inc. by Argosy Healthcare Partners, Merck KGaA, PerkinElmer Inc., QIAGEN GmbH, Siemens AG, and Thermo Fisher Scientific.

Market Segmentation & Coverage

This research report categorizes the Lab Automation in Protein Engineering Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Equipment, market is studied across Automated Liquid Handlers, Automated Plate Handlers, Automated Storage, Retrieval Systems, and Robotic Arms.
  • Based on Application, market is studied across Hospitals & Clinics and Laboratories & Academics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing protein engineering and awareness programs
      • 5.1.1.2. Increasing trend of digital transformation for laboratories with IoT
      • 5.1.1.3. Effective management of the huge amount of data generated
    • 5.1.2. Restraints
      • 5.1.2.1. Expensive Initial Setup
    • 5.1.3. Opportunities
      • 5.1.3.1. Increase in investments for lab automation in protein engineering
      • 5.1.3.2. Rise in R&D activities for improving accuracy and reproducibility of lab results
    • 5.1.4. Challenges
      • 5.1.4.1. Low adoption by medium-sized enterprises
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Lab Automation in Protein Engineering Market, by Equipment

  • 6.1. Introduction
  • 6.2. Automated Liquid Handlers
  • 6.3. Automated Plate Handlers
  • 6.4. Automated Storage
  • 6.5. Retrieval Systems
  • 6.6. Robotic Arms

7. Lab Automation in Protein Engineering Market, by Application

  • 7.1. Introduction
  • 7.2. Hospitals & Clinics
  • 7.3. Laboratories & Academics

8. Americas Lab Automation in Protein Engineering Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Lab Automation in Protein Engineering Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Lab Automation in Protein Engineering Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Agilent Technologies, Inc.
  • 3. Aurora Biomed Inc.
  • 4. Becton, Dickinson and Company
  • 5. bioMerieux SA
  • 6. BMG Labtech GmbH
  • 7. Danaher Corporation
  • 8. Endress+Hauser Group Services AG
  • 9. Eppendorf AG
  • 10. F. Hoffmann-La Roche AG
  • 11. General Biologicals Corporation
  • 12. Hamilton Company
  • 13. Hudson Robotics Inc. by Argosy Healthcare Partners
  • 14. Merck KGaA
  • 15. PerkinElmer Inc.
  • 16. QIAGEN GmbH
  • 17. Siemens AG
  • 18. Thermo Fisher Scientific
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦